« Microsoft is a Little Late in Smartphone Game | Main | Intuit Innovates, H&R Block Doesn't »

October 29, 2010

Merck Gives Investors a Headache

Merck & Co.'s third-quarter earnings dropped 90% from a year earlier, as the drug company booked a $950 million reserve for the anticipated resolution of a government investigation of its former pain drug Vioxx.

via online.wsj.com

You probably need an ibuprofen after their earning report...

Posted at 06:54 AM |

|

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451596069e20133f56e5feb970b

Listed below are links to weblogs that reference Merck Gives Investors a Headache:

Comments

Verify your Comment

Previewing your Comment

Posted by:  | 

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.